Titre :

History of bariatric surgery and COVID 19 outcomes in patients with type 2 diabetes: results from the CORONADO study.

Auteur(s) :

Blanchard, C. [Auteur]
Perennec, T. [Auteur]
Smati, S. [Auteur]
Tramunt, B. [Auteur]
Guyomarch, B. [Auteur]
Bigot-Corbel, E. [Auteur]
Bordier, L. [Auteur]
Borot, S. [Auteur]
Bourron, O. [Auteur]
Caussy, C. [Auteur]
Coffin-Boutreux, C. [Auteur]
Dutour, A. [Auteur]
Germain, N. [Auteur]
Gonfroy-Leymarie, C. [Auteur]
Meyer, L. [Auteur]
Prevost, G. [Auteur]
Roussel, R. [Auteur]
Seret-Bégué, D. [Auteur]
Thivolet, C. [Auteur]
Vergès, B. [Auteur]
Pichelin, M. [Auteur]
Gourdy, P. [Auteur]
Hadjadj, S. [Auteur]
Wargny, M. [Auteur]
Pattou, Francois [Auteur]
Recherche translationnelle sur le diabète (RTD) - U1190
Institut Européen de Génomique du Diabète - European Genomic Institute for Diabetes - FR 3508 [EGID]
Cariou, B. [Auteur]

Titre de la revue :

Obesity

Nom court de la revue :

Obesity (Silver Spring)

Numéro :

30

Pagination :

p. 599-605

Date de publication :

2022-03

ISSN :

1930-739X

Discipline(s) HAL :

Sciences du Vivant [q-bio]

Résumé en anglais : [en]

Objective This study assessed the impact of a history of metabolic and bariatric surgery (MBS) on the clinical outcomes in patients with type 2 diabetes (T2D) and severe obesity hospitalized for COVID-19. Methods In ...
Lire la suite >Objective This study assessed the impact of a history of metabolic and bariatric surgery (MBS) on the clinical outcomes in patients with type 2 diabetes (T2D) and severe obesity hospitalized for COVID-19. Methods In this post hoc analysis from the nationwide observational CORONADO (Coronavirus SARS-CoV2 and Diabetes Outcomes) study, patients with T2D and a history of MBS were matched with patients without MBS for age, sex, and BMI either at the time of MBS or on admission for COVID-19. The composite primary outcome (CPO) combined invasive mechanical ventilation and/or death within 7 and 28 days following admission. Results Out of 2,398 CORONADO participants, 20 had a history of MBS. When matching for BMI at the time of MBS and after adjustment for diabetes duration, the CPO occurred less frequently within 7 days (3 vs. 17 events, OR: 0.15 [0.01 to 0.94], p = 0.03) and 28 days (3 vs. 19 events, OR: 0.11 [0.01 to 0.71], p = 0.02) in patients with MBS (n = 16) vs. controls (n = 44). There was no difference in CPO rate between patients with MBS and controls when matching for BMI on admission. Conclusions These data are reassuring regarding COVID-19 prognosis in patients with diabetes and a history of MBS compared with those without MBS.Lire moins >

Langue :

Anglais

Audience :

Internationale

Vulgarisation :

Non

Établissement(s) :

Université de Lille
Inserm
CHU Lille

Collections :

• Recherche translationnelle sur le diabète (RTD) - U1190

Date de dépôt :

2024-01-19T22:50:44Z
2024-10-02T16:32:22Z